EspaƱa
India
Italia
ėķėƼźµ
ę„ę¬
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
EspaƱa
India
Italia
ėķėƼźµ
ę„ę¬
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
LeMaitre Vascular
LMAT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$101.30
1.15
1.15%
Pre-Market: 6:40 AM EDT
Get Report
Comment
LeMaitre Vascular (LMAT) Forecast
News
Earnings
LeMaitre Vascular (LMAT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for LeMaitre Vascular (NASDAQ:LMAT) Stock
LeMaitre Vascular Stock (NASDAQ: LMAT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Reported Earlier, LeMaitre Vascular Announces...
Benzinga Newsdesk
Monday, December 16, 2024
LeMaitre Vascular Announces Proposed $150M Ag...
Benzinga Newsdesk
Thursday, November 28, 2024
Strategic Sale: James John OConnor Decides To Exercise Options Worth $527K At LeMaitre Vascular
Benzinga Insights
Wednesday, November 27, 2024
Witnessing An Insider Decision, George LeMaitre Exercises Options Valued At $187K At LeMaitre Vascular
Benzinga Insights
Wednesday, November 20, 2024
Bridget Ross At LeMaitre Vascular Decides to Exercises Options Worth $276K
Benzinga Insights
Friday, November 01, 2024
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on LeMaitre...
Benzinga Newsdesk
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Benzinga Insights
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Thursday, October 31, 2024
LeMaitre Vascular Raises FY2024 GAAP EPS Guid...
Benzinga Newsdesk
LeMaitre Vascular Q3 2024 GAAP EPS $0.49 Beat...
Benzinga Newsdesk
Tuesday, October 15, 2024
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Benzinga Insights
Cantor Fitzgerald Initiates Coverage On LeMai...
Benzinga Newsdesk
Friday, September 20, 2024
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Wednesday, August 28, 2024
Acadia Healthcare Expands Behavioral Health Services in Iowa
Zacks
Monday, August 26, 2024
Lemaitre Vascular Announces Joseph P. Pellegr...
Benzinga Newsdesk
Tuesday, August 20, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Friday, August 02, 2024
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Thursday, August 01, 2024
LeMaitre Vascular Sees Q3 EPS $0.42-$0.46 Vs ...
Benzinga Newsdesk
LeMaitre Vascular Q2 2024 GAAP EPS $0.53 Beat...
Benzinga Newsdesk
Wednesday, June 26, 2024
GE HealthCare's New Tie-Up to Boost CVD Workflow
Zacks
Friday, May 31, 2024
Navigating 4 Analyst Ratings For LeMaitre Vascular
Benzinga Insights
Roth MKM Reinstates Buy on LeMaitre Vascular,...
Benzinga Newsdesk
Friday, May 03, 2024
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Thursday, May 02, 2024
LeMaitre Vascular Sees Q2 EPS $0.45-$0.50 vs ...
Benzinga Newsdesk
LeMaitre Vascular Q1 2024 GAAP EPS $0.44 Beat...
Benzinga Newsdesk
Friday, April 26, 2024
Stifel Upgrades LeMaitre Vascular to Buy, Rai...
Benzinga Newsdesk
Wednesday, March 27, 2024
Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular
Benzinga Insights
Tuesday, March 05, 2024
Insider Transaction: George LeMaitre Sells $6.94M Worth Of LeMaitre Vascular Shares
Benzinga Insights
Strategic Sale: Joseph Pellegrino JR Decides To Exercise Options Worth $1.08M At LeMaitre Vascular
Benzinga Insights
Wednesday, February 28, 2024
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
Benzinga Insights
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Tuesday, February 27, 2024
LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 vs ...
Benzinga Newsdesk
Recap: LeMaitre Vascular Q4 Earnings
Benzinga Insights
LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beat...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
A Preview Of LeMaitre Vascular's Earnings
Benzinga Insights
Tuesday, February 06, 2024
Keybanc Initiates Coverage On LeMaitre Vascul...
Benzinga Newsdesk
Thursday, December 28, 2023
George LeMaitre At LeMaitre Vascular Capitalizes: Options Exercised, Resulting In $350K
Benzinga Insights
Tuesday, December 12, 2023
Chairman and CEO At LeMaitre Vascular Sells $2.79M Of Stock
Benzinga Insights
Wednesday, November 29, 2023
LeMaitre Vascular Board Member Acquires 7,500 Shares After Exercising Company Stock Options
Benzinga Insights
Wednesday, November 22, 2023
Chairman and CEO at LeMaitre Vascular Exercises Options Worth $678K
Benzinga Insights
Wednesday, November 01, 2023
LeMaitre Vascular Sees Q4 EPS $0.34-$0.38 Vs ...
Benzinga Newsdesk
LeMaitre Vascular Q3 EPS $0.33 Beats $0.30 Es...
Benzinga Newsdesk
Show More
